We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$94.7M
AUM Growth
+$5.36M
(+6%)
Cap. Flow
+$2.1M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
109
New
5
Increased
19
Reduced
37
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.57M |
| 2 |
SKYT
SkyWater Technology
SKYT
|
+$1.18M |
| 3 |
8x8 Inc
EGHT
|
+$838K |
| 4 |
Usio Inc
USIO
|
+$566K |
| 5 |
Elutia
ELUT
|
+$255K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$969K |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$415K |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$335K |
| 4 |
RingCentral
RNG
|
+$221K |
| 5 |
QUMU
Qumu Corp.
QUMU
|
+$148K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.9% |
| 2 | Technology | 21.84% |
| 3 | Communication Services | 7.13% |
| 4 | Industrials | 6.74% |
| 5 | Consumer Staples | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Achieve Life Sciences
ACHV
$664M
| $534K | 0.56% |
218,100
| – | – |
|
52
ePlus
PLUS
$2.54B
| $531K | 0.56% |
12,000
| – | – |
|
53
Backblaze
BLZE
$1.19B
| $499K | 0.53% |
81,110
+7,500
| +10% | +$35.9K |
|
54
Option Care Health
OPCH
$3.55B
| $496K | 0.52% |
16,500
| – | – |
|
55
CVS Health
CVS
$133B
| $493K | 0.52% |
5,293
| – | – |
|
|
EGIO
56
DELISTED
Edgio, Inc. Common Stock
EGIO
| $473K | 0.5% |
10,475
-400
| -4% | -$30.8K |
|
|
SRXH
57
SRX Global
SRXH
$26.7M
| $472K | 0.5% |
448
+46
| +11% | +$75.6K |
|
|
58
Usio Inc
USIO
$62.1M
| $467K | 0.49% |
+282,888
| New | +$566K |
|
59
Fastenal
FAST
$57B
| $454K | 0.48% |
19,200
| – | – |
|
60
Journey Medical
DERM
$176M
| $434K | 0.46% |
225,800
+16,850
| +8% | +$33.3K |
|
61
Johnson & Johnson
JNJ
$614B
| $406K | 0.43% |
2,300
| – | – |
|
|
PRFT
62
DELISTED
Perficient Inc
PRFT
| $398K | 0.42% |
5,700
| – | – |
|
63
NXP Semiconductors
NXPI
$59.9B
| $387K | 0.41% |
2,450
| – | – |
|
64
US Bancorp
USB
$100B
| $379K | 0.4% |
8,684
| – | – |
|
65
Tactile Systems Technology
TCMD
$680M
| $370K | 0.39% |
32,234
+1,100
| +4% | +$9.68K |
|
66
ANI Pharmaceuticals
ANIP
$1.8B
| $343K | 0.36% |
8,526
| – | – |
|
67
Rockwell Medical
RMTI
$29.9M
| $331K | 0.35% |
32,627
+1,237
| +4% | +$13.2K |
|
|
VJET
68
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
| $324K | 0.34% |
141,000
-4,350
| -3% | -$12.1K |
|
69
Asure Software
ASUR
$254M
| $308K | 0.33% |
33,000
-3,000
| -8% | -$21.4K |
|
|
ASPU
70
DELISTED
ASPEN GROUP, INC.
ASPU
| $302K | 0.32% |
973,375
-24,750
| -2% | -$8.97K |
|
71
LifeVantage
LFVN
$86.2M
| $283K | 0.3% |
76,113
| – | – |
|
72
Village Farms International
VFF
$242M
| $276K | 0.29% |
205,750
+31,000
| +18% | +$59K |
|
73
BP
BP
$109B
| $267K | 0.28% |
7,650
| – | – |
|
74
Ionis Pharmaceuticals
IONS
$9.15B
| $242K | 0.26% |
6,400
| – | – |
|
75
Quest Diagnostics
DGX
$25.8B
| $231K | 0.24% |
+1,475
| New | +$212K |
|
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Perkins Capital Management held 109 positions worth $94.7M, up 6% from $89.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management's Q4 2022 filing shows 5 new, 19 increased, 37 reduced and 9 closed positions. Its largest new stake was SkyWater Technology: 140,000 shares worth $995K. The largest sale was CareDx, an estimated $969K.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 57% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q4 2022 buy was SkyWater Technology: 140,000 shares worth $995K.
- Perkins Capital Management added most to Augmedix, Inc. Common Stock in Q4 2022, an estimated $1.57M increase.
- Perkins Capital Management's biggest Q4 2022 reduction was Biolase, Inc., cutting an estimated $124K.
- Perkins Capital Management fully exited CareDx in Q4 2022, selling an estimated $969K.
- Perkins Capital Management's ten largest holdings make up 36% of its $94.7M portfolio in Q4 2022.
- Perkins Capital Management opened 5 new positions and closed 9 in Q4 2022.
- Perkins Capital Management's portfolio value rose 6% quarter-over-quarter to $94.7M.
Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.